{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:24:54Z","timestamp":1793121894978,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["2013-14113"],"award-info":[{"award-number":["2013-14113"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008733","name":"H\u00f8rslev-Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008269","name":"L\u00e6ge Sophus Carl Emil Friis og hustru Olga Doris Friis' Legat","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The lack of essential information when reporting animal studies causing lower reproducibility has been stressed for decades. The ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines were first published in 2010, to improve reporting of animal research, making in vivo studies more transparent thereby improving the scientific quality. Regardless of an endorsement from the scientific community, there is still a continuous need to improve animal research reporting, which unfortunately also is the case in the field of Niemann-Pick type C disease (NPC). NPC is a lipid storage disorder, caused by mutations in either the <jats:italic>Npc1<\/jats:italic> or <jats:italic>Npc2<\/jats:italic> gene. Despite years of research, no cure for this fatal disease exists. In 2020, an updated version of the ARRIVE guidelines (ARRIVE 2.0), was published, describing the ten most essential elements to be included when reporting pre-clinical studies. Here we systematically reviewed the compliance with the ARRIVE guidelines using the \u201cARRIVE Essential 10\u201d checklist in a series of pre-clinical studies investigating gene therapy as a treatment strategy for NPC. None of the reviewed papers fulfilled the ARRIVE 2.0 guidelines. Information regarding sample size, randomization, blinding, and statistical methodology was lacking. Hopefully, the newly updated ARRIVE guidelines will aid researchers in planning and publishing in vivo experiments in the future. More awareness of the importance of including these essential items is needed, both from editors, reviewers and researchers, for complete endorsement of the ARRIVE guidelines in the scientific community.<\/jats:p>","DOI":"10.1186\/s13023-024-03479-1","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T08:38:16Z","timestamp":1746520696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reporting preclinical gene therapy studies in the field of Niemann-Pick type C disease according to the ARRIVE guidelines"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6535-3729","authenticated-orcid":false,"given":"Charlotte Laurfelt Munch","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2086-4693","authenticated-orcid":false,"given":"Annette","family":"Burkhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9989-0207","authenticated-orcid":false,"given":"Torben","family":"Moos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3144-7150","authenticated-orcid":false,"given":"Louiza Bohn","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"issue":"1","key":"3479_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1371\/journal.pgen.0010007","volume":"1","author":"DC Ko","year":"2005","unstructured":"Ko DC, Milenkovic L, Beier SM, Manuel H, Buchanan JA, Scott MP. Cell-autonomous death of cerebellar purkinje neurons with autophagy in niemann-pick type C disease. PLOS Genet. 2005;1(1):81\u201395.","journal-title":"PLOS Genet"},{"key":"3479_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-5-16","volume":"5","author":"MT Vanier","year":"2010","unstructured":"Vanier MT. Niemann-Pick disease type C. Orphanet J Rare Dis. 2010;5:16.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3479_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","volume":"106","author":"MC Patterson","year":"2012","unstructured":"Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F. Recommendations for the diagnosis and management of Niemann-Pick disease type C: An update. Mol Genet Metab. 2012;106(3):330\u201344.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"3479_CR4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ymgme.2016.06.004","volume":"118","author":"MT Vanier","year":"2016","unstructured":"Vanier MT, Gissen P, Bauer P, Coll MJ, Burlina A, Hendriksz CJ, et al. Diagnostic tests for Niemann-Pick disease type C (NP-C): A critical review. Mol Genet Metab. 2016;118(4):244\u201354.","journal-title":"Mol Genet Metab"},{"issue":"1\u20132","key":"3479_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ymgme.2009.06.008","volume":"98","author":"JE Wraith","year":"2009","unstructured":"Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, Mengel E, et al. Recommendations on the diagnosis and management of Niemann-Pick disease type C. Mol Genet Metab. 2009;98(1\u20132):152\u201365.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"3479_CR6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/jimd.12245","volume":"43","author":"MC Patterson","year":"2020","unstructured":"Patterson MC, Garver WS, Giugliani R, Imrie J, Jahnova H, Meaney FJ, et al. Long-term survival outcomes of patients with Niemann-Pick disease type C receiving miglustat treatment: a large retrospective observational study. J Inherit Metab Dis. 2020;43(5):1060\u20139.","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"3479_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","volume":"6","author":"MC Patterson","year":"2007","unstructured":"Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol. 2007;6(9):765\u201372.","journal-title":"Lancet Neurol"},{"issue":"23","key":"3479_CR8","doi-asserted-by":"publisher","first-page":"8979","DOI":"10.3390\/ijms21238979","volume":"21","author":"V Pallottini","year":"2020","unstructured":"Pallottini V, Pfrieger FW. Understanding and treating niemann-pick type C disease: models matter. Int J Mol Sci. 2020;21(23):8979.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3479_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2005;2(1):3\u201314.","journal-title":"NeuroRx"},{"issue":"1","key":"3479_CR10","first-page":"52","volume":"26","author":"RJ Chandler","year":"2017","unstructured":"Chandler RJ, Williams IM, Gibson AL, Davidson CD, Incao AA, Hubbard BT, et al. Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1. Hum Mol Genet. 2017;26(1):52\u201364.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"3479_CR11","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202101040","volume":"4","author":"CD Davidson","year":"2021","unstructured":"Davidson CD, Gibson AL, Gu T, Baxter LL, Deverman BE, Beadle K, et al. Improved systemic AAV gene therapy with a neurotrophic capsid in Niemann-Pick disease type C1 mice. Life Sci Alliance. 2021;4(10): e202101040.","journal-title":"Life Sci Alliance"},{"issue":"11\u201312","key":"3479_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/hum.2020.175","volume":"32","author":"Y Kurokawa","year":"2021","unstructured":"Kurokawa Y, Osaka H, Kouga T, Jimbo E, Muramatsu K, Nakamura S, et al. Gene therapy in a mouse model of Niemann-Pick Disease Type C1. Hum Gene Ther. 2021;32(11\u201312):589\u201398.","journal-title":"Hum Gene Ther"},{"issue":"3","key":"3479_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1194\/jlr.M071274","volume":"58","author":"C Xie","year":"2017","unstructured":"Xie C, Gong X-M, Luo J, Li B-L, Song B-L. AAV9-NPC1 significantly ameliorates Purkinje cell death and behavioral abnormalities in mouse NPC disease. J Lipid Res. 2017;58(3):512\u20138.","journal-title":"J Lipid Res"},{"key":"3479_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.expneurol.2018.04.001","volume":"306","author":"S Markmann","year":"2018","unstructured":"Markmann S, Christie-Reid JJ, Rosenberg JB, De BP, Kaminsky SM, Crystal RG, et al. Attenuation of the Niemann-Pick type C2 disease phenotype by intracisternal administration of an AAVrh.10 vector expressing Npc2. Exp Neurol. 2018;306:22\u201333.","journal-title":"Exp Neurol"},{"issue":"17","key":"3479_CR15","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1093\/hmg\/ddy212","volume":"27","author":"MP Hughes","year":"2018","unstructured":"Hughes MP, Smith DA, Morris L, Fletcher C, Colaco A, Huebecker M, et al. AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann-Pick type C1 disease. Hum Mol Genet. 2018;27(17):3079\u201398.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"3479_CR16","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3390\/cells12121619","volume":"12","author":"MP Hughes","year":"2023","unstructured":"Hughes MP, Nelvagal HR, Coombe-Tennant O, Smith D, Smith C, Massaro G, et al. A novel small NPC1 promoter enhances AAV-mediated gene therapy in mouse models of Niemann-Pick type C1 disease. Cells. 2023;12(12):1619.","journal-title":"Cells"},{"issue":"6","key":"3479_CR17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1017\/neu.2019.40","volume":"31","author":"AKO Alstrup","year":"2019","unstructured":"Alstrup AKO, Sonne C. 3Rs as part of preclinical neuropsychiatric translational crisis, and ARRIVE guidelines as part of solution. Acta Neuropsychiatr. 2019;31(6):348\u20139.","journal-title":"Acta Neuropsychiatr"},{"issue":"6","key":"3479_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLOS Biol. 2010;8(6): e1000412.","journal-title":"PLOS Biol"},{"issue":"4","key":"3479_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/ilar.43.4.244","volume":"43","author":"MFW Festing","year":"2002","unstructured":"Festing MFW, Altman DG. Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J. 2002;43(4):244\u201358.","journal-title":"ILAR J"},{"issue":"18","key":"3479_CR20","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1113\/JP280389","volume":"598","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. J Physiol. 2020;598(18):3793\u2013801.","journal-title":"J Physiol"},{"issue":"11","key":"3479_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004194","volume":"9","author":"JEN Gulin","year":"2015","unstructured":"Gulin JEN, Rocco DM, Garc\u00eda-Bournissen F. Quality of reporting and adherence to ARRIVE guidelines in animal studies for chagas disease preclinical drug research: a systematic review. PLoS Negl Trop Dis. 2015;9(11): e0004194.","journal-title":"PLoS Negl Trop Dis"},{"key":"3479_CR22","doi-asserted-by":"publisher","first-page":"13334","DOI":"10.1038\/s41598-020-70290-w","volume":"10","author":"D Jiang","year":"2020","unstructured":"Jiang D, Lee H, Pardridge WM. Plasmid DNA gene therapy of the Niemann-Pick C1 mouse with transferrin receptor-targeted trojan horse liposomes. Sci Rep. 2020;10:13334.","journal-title":"Sci Rep"},{"issue":"4","key":"3479_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/10888705.2018.1423972","volume":"21","author":"V Richter","year":"2018","unstructured":"Richter V, Muche R, Mayer B. How much confidence do we need in animal experiments? Statistical assumptions in sample size estimation. J Appl Anim Welf Sci. 2018;21(4):325\u201333.","journal-title":"J Appl Anim Welf Sci"},{"issue":"11","key":"3479_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0275962","volume":"17","author":"BS Kousholt","year":"2022","unstructured":"Kousholt BS, Praestegaard KF, Stone JC, Fick Thomsen A, Johansen TT, Ritskes-Hoitingaid M, et al. Reporting quality in preclinical animal experimental research in 2009 and 2018: a nationwide systematic investigation. PLoS ONE. 2022;17(11): e0275962.","journal-title":"PLoS ONE"},{"issue":"10","key":"3479_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pbio.1002273","volume":"13","author":"MR Macleod","year":"2015","unstructured":"Macleod MR, Lawson McLean A, Kyriakopoulou A, Serghiou S, de Wilde A, Sherratt N, et al. Risk of bias in reports of in vivo research: A focus for improvement. PLoS Biol. 2015;13(10):1\u201312.","journal-title":"PLoS Biol"},{"issue":"2","key":"3479_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4085\/1062-6050-43.2.215","volume":"43","author":"M Kang","year":"2008","unstructured":"Kang M, Ragan BG, Park JH. Issues in outcomes research: an overview of randomization techniques for clinical trials. J Athl Train. 2008;43(2):215.","journal-title":"J Athl Train"},{"issue":"6","key":"3479_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098856","volume":"9","author":"JA Hirst","year":"2014","unstructured":"Hirst JA, Howick J, Aronson JK, Roberts N, Perera R, Koshiaris C, et al. The need for randomization in animal trials: an overview of systematic reviews. PLoS ONE. 2014;9(6): e98856.","journal-title":"PLoS ONE"},{"issue":"8","key":"3479_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237096","volume":"15","author":"R Van Eenige","year":"2020","unstructured":"Van Eenige R, Verhave PS, Koemans PJ, Tiebosch IACW, Rensen PCN, Kooijman S. RandoMice, a novel, user-friendly randomization tool in animal research. PLoS ONE. 2020;15(8): e0237096.","journal-title":"PLoS ONE"},{"issue":"16","key":"3479_CR29","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.1073\/pnas.0308456101","volume":"101","author":"DE Sleat","year":"2004","unstructured":"Sleat DE, Wiseman JA, El-Banna M, Price SM, Verot L, Shen MM, et al. Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc Natl Acad Sci U S A. 2004;101(16):5886\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3479_CR30","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hep.20868","volume":"42","author":"EP Beltroy","year":"2005","unstructured":"Beltroy EP, Richardson JA, Horton JD, Turley SD, Dietschy JM. Cholesterol accumulation and liver cell death in mice with Niemann-Pick type C disease. Hepatology. 2005;42(4):886\u201393.","journal-title":"Hepatology"},{"issue":"11","key":"3479_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027287","volume":"6","author":"GK Nielsen","year":"2011","unstructured":"Nielsen GK, Dagnaes-Hansen F, Holm IE, Meaney S, Symula D, Andersen NT, et al. Protein replacement therapy partially corrects the cholesterol-storage phenotype in a mouse model of Niemann-Pick type C2 disease. PLoS ONE. 2011;6(11): e27287.","journal-title":"PLoS ONE"},{"issue":"4","key":"3479_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/jnen\/64.4.323","volume":"64","author":"H Li","year":"2005","unstructured":"Li H, Repa JJ, Valasek MA, Beltroy EP, Turley SD, German DC, et al. Molecular, anatomical, and biochemical events associated with neurodegeneration in mice with Niemann-Pick type C disease. J Neuropathol Exp Neurol. 2005;64(4):323\u201333.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"3479_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/cne.10522","volume":"456","author":"JR Sarna","year":"2003","unstructured":"Sarna JR, Larouche M, Marzban H, Sillitoe RV, Rancourt DE, Hawkes R. Patterned Purkinje cell degeneration in mouse models of Niemann-Pick type C disease. J Comp Neurol. 2003;456(3):279\u201391.","journal-title":"J Comp Neurol"},{"issue":"1\u20132","key":"3479_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jns.2007.11.018","volume":"268","author":"Z Luan","year":"2008","unstructured":"Luan Z, Saito Y, Miyata H, Ohama E, Ninomiya H, Ohno K. Brainstem neuropathology in a mouse model of Niemann-Pick disease type C. J Neurol Sci. 2008;268(1\u20132):108\u201316.","journal-title":"J Neurol Sci"},{"issue":"1","key":"3479_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","volume":"13","author":"T Geberhiwot","year":"2018","unstructured":"Geberhiwot T, Moro A, Dardis A, Ramaswami U, Sirrs S, Marfa MP, et al. Consensus clinical management guidelines for Niemann-Pick disease type C. Orphanet J Rare Dis. 2018;13(1):50.","journal-title":"Orphanet J Rare Dis"},{"key":"3479_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2023.103880","volume":"126","author":"CLM Rasmussen","year":"2023","unstructured":"Rasmussen CLM, Thomsen LB, Heegaard CW, Moos T, Burkhart A. The Npc2Gt(LST105)BygNya mouse signifies pathological changes comparable to human Niemann-Pick type C2 disease. Mol Cell Neurosci. 2023;126: 103880.","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"3479_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-4328(01)00380-1","volume":"132","author":"V V\u00f5ikar","year":"2002","unstructured":"V\u00f5ikar V, Rauvala H, Ikonen E. Cognitive deficit and development of motor impairment in a mouse model of Niemann-Pick type C disease. Behav Brain Res. 2002;132(1):1\u201310.","journal-title":"Behav Brain Res"},{"issue":"1","key":"3479_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jneumeth.2007.09.009","volume":"168","author":"ER Whitney","year":"2008","unstructured":"Whitney ER, Kemper TL, Rosene DL, Bauman ML, Blatt GJ. Calbindin-D28k is a more reliable marker of human Purkinje cells than standard Nissl stains: a stereological experiment. J Neurosci Methods. 2008;168(1):42\u20137.","journal-title":"J Neurosci Methods"},{"key":"3479_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mcn.2014.06.003","volume":"61","author":"I Buard","year":"2014","unstructured":"Buard I, Pfrieger FW. Relevance of neuronal and glial NPC1 for synaptic input to cerebellar Purkinje cells. Mol Cell Neurosci. 2014;61:65\u201371.","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"3479_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002106","volume":"13","author":"ML Head","year":"2015","unstructured":"Head ML, Holman L, Lanfear R, Kahn AT, Jennions MD. The extent and consequences of P-hacking in science. PLOS Biol. 2015;13(3): e1002106.","journal-title":"PLOS Biol"},{"issue":"8","key":"3479_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003081","volume":"3","author":"K Dwan","year":"2008","unstructured":"Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE. 2008;3(8): e3081.","journal-title":"PLoS ONE"},{"key":"3479_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2022.869511","volume":"16","author":"SR Ten","year":"2022","unstructured":"Ten SR. Points to improve reproducibility and translation of animal research. Front Behav Neurosci. 2022;16: 869511.","journal-title":"Front Behav Neurosci"},{"issue":"7","key":"3479_CR43","doi-asserted-by":"publisher","first-page":"1001609","DOI":"10.1371\/journal.pbio.1001609","volume":"11","author":"KK Tsilidis","year":"2013","unstructured":"Tsilidis KK, Panagiotou OA, Sena ES, Aretouli E, Evangelou E. Evaluation of excess significance bias in animal studies of neurological diseases. PLoS Biol. 2013;11(7):1001609.","journal-title":"PLoS Biol"},{"issue":"1","key":"3479_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4097\/kjae.2016.69.1.8","volume":"69","author":"FS Nahm","year":"2016","unstructured":"Nahm FS. Nonparametric statistical tests for the continuous data: the basic concept and the practical use. Korean J Anesthesiol. 2016;69(1):8.","journal-title":"Korean J Anesthesiol"},{"issue":"2","key":"3479_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/0023677217724823","volume":"52","author":"AJ Smith","year":"2018","unstructured":"Smith AJ, Clutton RE, Lilley E, Hansen KEA, Brattelid T. PREPARE: guidelines for planning animal research and testing. Lab Anim. 2018;52(2):135\u201341.","journal-title":"Lab Anim"},{"issue":"23","key":"3479_CR46","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1182\/bloodadvances.2017006932","volume":"1","author":"C Borsotti","year":"2017","unstructured":"Borsotti C, Danzl NM, Nauman G, H\u00f6lzl MA, French C, Chavez E, et al. HSC extrinsic sex-related and intrinsic autoimmune disease\u2013related human B-cell variation is recapitulated in humanized mice. Blood Adv. 2017;1(23):2007\u201318.","journal-title":"Blood Adv"},{"issue":"18","key":"3479_CR47","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1182\/blood-2009-10-249326","volume":"115","author":"F Notta","year":"2010","unstructured":"Notta F, Doulatov S, Dick JE. Engraftment of human hematopoietic stem cells is more efficient in female NOD\/SCID\/IL-2Rgc-null recipients. Blood. 2010;115(18):3704\u20137.","journal-title":"Blood"},{"issue":"1","key":"3479_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms15475","volume":"8","author":"NA Karp","year":"2017","unstructured":"Karp NA, Mason J, Beaudet AL, Benjamini Y, Bower L, Braun RE, et al. Prevalence of sexual dimorphism in mammalian phenotypic traits. Nat Commun. 2017;8(1):1\u201312.","journal-title":"Nat Commun"},{"issue":"662","key":"3479_CR49","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1126\/scisignal.abd2494","volume":"13","author":"KS Abd-Elrahman","year":"2020","unstructured":"Abd-Elrahman KS, Albaker A, De Souza JM, Ribeiro FM, Schlossmacher MG, Tiberi M, et al. A\u03b2 oligomers induce pathophysiological mGluR5 signaling in Alzheimer\u2019s disease model mice in a sex-selective manner. Sci Signal. 2020;13(662):2494.","journal-title":"Sci Signal"},{"issue":"4","key":"3479_CR50","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/path.5477","volume":"251","author":"T Houben","year":"2020","unstructured":"Houben T, Bitorina AV, Oligschlaeger Y, Jeurissen MLJ, Rensen S, K\u00f6hler SE, et al. Sex-opposed inflammatory effects of 27-hydroxycholesterol are mediated via differences in estrogen signaling. J Pathol. 2020;251(4):429.","journal-title":"J Pathol"},{"issue":"4","key":"3479_CR51","first-page":"461","volume":"45","author":"EC Bascu\u00f1an-Castillo","year":"2004","unstructured":"Bascu\u00f1an-Castillo EC, Erickson RP, Howison CM, Hunter RJ, Heidenreich RH, Hicks C, et al. Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C. J Appl Genet. 2004;45(4):461\u20137.","journal-title":"J Appl Genet"},{"issue":"4","key":"3479_CR52","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ymgme.2019.02.004","volume":"126","author":"SE Bianconi","year":"2019","unstructured":"Bianconi SE, Hammond DI, Farhat NY, Dang Do A, Jenkins K, Cougnoux A, et al. Evaluation of age of death in Niemann-Pick disease, type C: Utility of disease support group websites to understand natural history. Mol Genet Metab. 2019;126(4):466\u20139.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"3479_CR53","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ymgme.2019.10.004","volume":"129","author":"A Cougnoux","year":"2020","unstructured":"Cougnoux A, Fellmeth M, Gu T, Davidson CD, Gibson AL, Pavan WJ, et al. Maternal immune activation modifies the course of Niemann-Pick disease, type C1 in a gender specific manner. Mol Genet Metab. 2020;129(2):165\u201370.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"3479_CR54","first-page":"96","volume":"43","author":"CD Steel","year":"2014","unstructured":"Steel CD, Stephens AL, Hahto SM, Singletary SJ, Ciavarra RP. Comparison of the lateral tail vein and the retro-orbital venous sinus as routes of intravenous drug delivery in a transgenic mouse model. Lab Anim. 2014;43(3):96\u20139.","journal-title":"Lab Anim"},{"issue":"2","key":"3479_CR55","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1258\/la.2008.008020","volume":"43","author":"EL Stokes","year":"2009","unstructured":"Stokes EL, Flecknell PA, Richardson CA. Reported analgesic and anaesthetic administration to rodents undergoing experimental surgical procedures. Lab Anim. 2009;43(2):149\u201354.","journal-title":"Lab Anim"},{"issue":"3","key":"3479_CR56","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4103\/2229-3485.100662","volume":"3","author":"MP Barde","year":"2012","unstructured":"Barde MP, Barde PJ. What to use to express the variability of data: Standard deviation or standard error of mean? Perspect Clin Res. 2012;3(3):113.","journal-title":"Perspect Clin Res"},{"issue":"4","key":"3479_CR57","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1469-185X.2007.00027.x","volume":"82","author":"S Nakagawa","year":"2007","unstructured":"Nakagawa S, Cuthill IC. Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev. 2007;82(4):591\u2013605.","journal-title":"Biol Rev"},{"issue":"21","key":"3479_CR58","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.2106\/JBJS.19.01001","volume":"101","author":"TW Bauer","year":"2019","unstructured":"Bauer TW, Bechtold JE, Swiontkowski MF. JBJS will require adherence to ARRIVE guidelines for animal research to reduce bias and improve quality of reporting. J Bone Jt Surg - Am. 2019;101(21):1891\u20133.","journal-title":"J Bone Jt Surg - Am"},{"issue":"5","key":"3479_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197882","volume":"13","author":"V Leung","year":"2018","unstructured":"Leung V, Rousseau-Blass F, Beauchamp G, Pang DSJ. ARRIVE has not ARRIVEd: support for the ARRIVE (animal research: reporting of in vivo experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia. PLoS ONE. 2018;13(5): e0197882.","journal-title":"PLoS ONE"},{"issue":"12","key":"3479_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165999","volume":"11","author":"TS Reichlin","year":"2016","unstructured":"Reichlin TS, Vogt L, W\u00fcrbel H. The researchers\u2019 view of scientific rigor\u2014survey on the conduct and reporting of In vivo research. PLoS ONE. 2016;11(12): e0165999.","journal-title":"PLoS ONE"},{"issue":"1","key":"3479_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41073-019-0069-3","volume":"4","author":"K Hair","year":"2019","unstructured":"Hair K, Macleod MR, Sena ES. A randomised controlled trial of an intervention to improve compliance with the ARRIVE guidelines (IICARus). Res Integr Peer Rev. 2019;4(1):1\u201317.","journal-title":"Res Integr Peer Rev"},{"issue":"1","key":"3479_CR62","doi-asserted-by":"publisher","first-page":"e1002331","DOI":"10.1371\/journal.pbio.1002331","volume":"14","author":"C Holman","year":"2016","unstructured":"Holman C, Piper SK, Grittner U, Diamantaras AA, Kimmelman J, Siegerink B, et al. Where have all the rodents gone? The effects of attrition in experimental research on cancer and stroke. PLoS Biol. 2016;14(1):e1002331.","journal-title":"PLoS Biol"},{"issue":"5","key":"3479_CR63","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/SHK.0000000000001544","volume":"55","author":"PS Reynolds","year":"2021","unstructured":"Reynolds PS, Garvan CW. Preclinical research reporting in shock: room for improvement. Shock. 2021;55(5):573\u201380.","journal-title":"Shock"},{"issue":"12","key":"3479_CR64","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1161\/CIRCRESAHA.117.310628","volume":"120","author":"FD Ramirez","year":"2017","unstructured":"Ramirez FD, Motazedian P, Jung RG, Di Santo P, Macdonald ZD, Moreland R, et al. Methodological rigor in preclinical cardiovascular studies. Circ Res. 2017;120(12):1916\u201326.","journal-title":"Circ Res"},{"issue":"19","key":"3479_CR65","first-page":"3005","volume":"13","author":"BS Kousholt","year":"2023","unstructured":"Kousholt BS, Pr\u00e6stegaard KF, Stone JC, Thomsen AF, Johansen TT, Ritskes-Hoitinga M, et al. Reporting of 3Rs approaches in preclinical animal experimental studies\u2014a nationwide study. Anim. 2023;13(19):3005.","journal-title":"Anim"},{"issue":"11","key":"3479_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166733","volume":"11","author":"MT Avey","year":"2016","unstructured":"Avey MT, Moher D, Sullivan KJ, Fergusson D, Griffin G, Grimshaw JM, et al. The devil is in the details: incomplete reporting in preclinical animal research. PLoS ONE. 2016;11(11): e0166733.","journal-title":"PLoS ONE"}],"updated-by":[{"DOI":"10.1186\/s13023-025-03826-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000}}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03479-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03479-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03479-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T16:01:43Z","timestamp":1749571303000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03479-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3479"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03479-1","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13023-025-03826-w","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"20 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Section has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13023-025-03826-w","URL":"https:\/\/doi.org\/10.1186\/s13023-025-03826-w","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}